119 related articles for article (PubMed ID: 576352)
1. Michaëlis--Menten kinetics of phenazone elimination in the perfused pig liver.
Andreasen B; Tonnesen K; Rabol A; Keiding S
Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40(1):1-13. PubMed ID: 576352
[TBL] [Abstract][Full Text] [Related]
2. Hepatic galactose elimination kinetics in the intact pig.
Keiding S; Johansen S; Winkler K
Scand J Clin Lab Invest; 1982 May; 42(3):253-9. PubMed ID: 7134810
[TBL] [Abstract][Full Text] [Related]
3. [An attempt at assessment of biotransformation activity in calves' liver on the basis of the rate of antipyrine elimination from saliva].
Janus K; Baranow-Baranowski S; Jakubowska D
Pol Arch Weter; 1991; 31(3-4):65-71. PubMed ID: 1842615
[TBL] [Abstract][Full Text] [Related]
4. Phenazone metabolism during perfusion of isolated guinea pig liver.
Tarnawski A; Goszcz A; Bogdał J; Barylak H; Mach T
Pol J Pharmacol Pharm; 1978; 30(5):621-6. PubMed ID: 751005
[TBL] [Abstract][Full Text] [Related]
5. Michaelis-Menten kinetics of galactose elimination by the isolated perfused pig liver.
Keiding S; Johansen S; Winkler K; Tonnesen K; Tygstrup N
Am J Physiol; 1976 May; 230(5):1302-13. PubMed ID: 1275072
[TBL] [Abstract][Full Text] [Related]
6. Phenazone as a marker of liver-metabolic function in patients with acute leukemia.
Wiela-Hojenska A; Orzechowska-Juzwenko K; Usnarska-Zubkiewicz L; Kotlarek-Haus S; Hurkacz M
Int J Clin Pharmacol Ther; 1999 May; 37(5):234-7. PubMed ID: 10363621
[TBL] [Abstract][Full Text] [Related]
7. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
Engel G; Hofmann U; Heidemann H; Cosme J; Eichelbaum M
Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486
[TBL] [Abstract][Full Text] [Related]
8. Galactose removal kinetics during hypoxia in perfused pig liver: reduction of Vmax, but not of intrinsic clearance Vmax/Km.
Keiding S; Johansen S; Tygstrup N
Eur J Clin Invest; 1990 Jun; 20(3):305-9. PubMed ID: 2114992
[TBL] [Abstract][Full Text] [Related]
9. Hepatic elimination of femoxetine in pig.
Bechgaard E; Keiding S; Lund J; Christiansen LA
Acta Pharmacol Toxicol (Copenh); 1983 Jan; 52(1):1-7. PubMed ID: 6837320
[TBL] [Abstract][Full Text] [Related]
10. [Biotransformation of phenazone and sulfadimidine as markers of liver metabolism of drug and xenobiotic oxidation and acetylation in women with breast cancer].
Orzechowska-Juzwenko K; Wiela-Hojeńska A; Milejski P; Cieślińska A; Hudziec P; Adamska M
Przegl Lek; 1997; 54(2):103-6. PubMed ID: 9198818
[TBL] [Abstract][Full Text] [Related]
11. Effect of chronic exposure to carbon disulfide on biotransformation of phenazone in rabbits.
Orzechowska-Juzwenko K; Wronska-Nofer T; Wiela A; Milejski P; Laurman W
Toxicol Lett; 1984 Aug; 22(2):171-4. PubMed ID: 6474507
[TBL] [Abstract][Full Text] [Related]
12. Metabolic efficiency of the liver in patients with breast cancer as determined by pharmacokinetics of phenazone.
Orzechowska-Juzwenko K; Wiela A; Cieślińska A; Roszkowska E
Cancer; 1987 May; 59(9):1607-10. PubMed ID: 3828961
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of phenazone in man after hydrocortisone administration.
Elfström J; Lindgren S
Eur J Clin Pharmacol; 1978 Mar; 13(1):69-72. PubMed ID: 639836
[TBL] [Abstract][Full Text] [Related]
14. Direct measurement of aminopyrine N-demethylase and antipyrine hydroxylase activities in a monolayer rat primary isolated hepatocyte system.
Kotake AN
Biochem Pharmacol; 1981 Sep; 30(17):2473-9. PubMed ID: 21043248
[TBL] [Abstract][Full Text] [Related]
15. [Effect of acute biliary pancreatitis on liver metabolism of phenazone].
Hartleb M; Nowak A; Nowakowska-Duława E; Mańczyk I; Becker A; Kacperek T
Pol Arch Med Wewn; 1990 Mar; 83(3):104-10. PubMed ID: 2216933
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the capacity of the liver for phenazone biotransformation in patients with uremia on peritoneal dialysis].
Grzegorzewska A; Lowicki Z; Chmara E; Mrozikiewicz A; Baczyk K
Pol Tyg Lek; 1990 Apr 16-30; 45(16-18):339-41. PubMed ID: 2235722
[TBL] [Abstract][Full Text] [Related]
17. The effects of industrial lead poisoning on cytochrome P450 mediated phenazone (antipyrine) hydroxylation.
Meredith PA; Campbell BC; Moore MR; Goldberg A
Eur J Clin Pharmacol; 1977 Nov; 12(3):235-9. PubMed ID: 412677
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetics of dimeylaminophenazone, 4-aminophenazone and phenazone in rats of various ages].
Klinger W
Arch Int Pharmacodyn Ther; 1969 Aug; 180(2):309-22. PubMed ID: 5348404
[No Abstract] [Full Text] [Related]
19. [Effect of disorders of thyroid function on phenazone pharmacokinetics].
Bolanowski M; Orzechowska-Juzwenko K; Gruszka S; Szymczak J
Pol Tyg Lek; 1990 Feb 5-12; 45(6-7):136-9. PubMed ID: 2216953
[TBL] [Abstract][Full Text] [Related]
20. The effect of enzyme induction and inhibition on the disposition of the xanthine-related nootropic drug ethimizol in perfused liver and hepatocytes of rats.
Kukan M; Bezek S; Stefek M; Trnovec T; Durisová M; Piotrovskiy LB
Drug Metab Dispos; 1990; 18(1):96-101. PubMed ID: 1970784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
